Eight Cycles of BEACOPP Escalated Compared with 4 Cycles of BEACOPP Escalated Followed by 4 Cycles of BEACOPP Baseline with Our without Radiotherapy in Patients in Advanced Stage Hodgkin Lymphoma (HL): Final Analysis of the Randomised HD12 Trial of the German Hodgkin Study Group (GHSG)

被引：0
|
作者：
Diehl, Volker
Haverkamp, Heinz [1 ]
Mueller, Rolf Peter [2 ]
Eich, Hans Theodor [2 ]
Mueller-Hermelink, Hans Konrad [3 ]
Cerny, Thomas [4 ]
Markova, Jana [5 ]
Ho, Anthony [6 ]
Kanz, Lothar [7 ]
Greil, Richard [8 ]
Hiddemann, Wolfgang [9 ]
Engert, Andreas [2 ]
机构：
[1] Univ Cologne, Dept Internal Med 1, GHSG, Cologne, Germany
[2] Univ Cologne, Dept Radiotherapy, Cologne, Germany
[3] Univ Wurzburg, Dept Pathol, Wurzburg, Germany
[4] Kanionsspital St Gallen, Dept Oncol, St Gallen, Switzerland
[5] Fak Nemocnice, Clin Hematol, Prague, Czech Republic
[6] Univ Heidelberg, Dept Hematol & Oncol, Heidelberg, Germany
[7] Univ Tubingen, D-72074 Tubingen, Germany
[8] Salzburg Univ, Dept Internal Med 3, A-5020 Salzburg, Austria
[9] Univ Munic, Dept Internal Med 3, Munic, Germany
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：552 / 553
页数：2
相关论文
共 50 条
  • [41] Brentuximab vedotin-containing escalated BEACOPP variants for newly diagnosed advanced-stage classical Hodgkin lymphoma: follow-up analysis of a randomized phase II study from the German Hodgkin Study Group
    Damaschin, Carla
    Goergen, Helen
    Kreissl, Stefanie
    Pluetschow, Annette
    Breywisch, Frank
    Mathas, Stephan
    Meissner, Julia
    Soekler, Martin
    Topp, Max S.
    Vucinic, Vladan
    Zimmermann, Andreas
    von Tresckow, Bastian
    Fuchs, Michael
    Engert, Andreas
    Borchmann, Peter
    Eichenauer, Dennis A.
    LEUKEMIA, 2022, 36 (02) : 580 - 582
  • [42] Brentuximab vedotin-containing escalated BEACOPP variants for newly diagnosed advanced-stage classical Hodgkin lymphoma: follow-up analysis of a randomized phase II study from the German Hodgkin Study Group
    Carla Damaschin
    Helen Goergen
    Stefanie Kreissl
    Annette Plütschow
    Frank Breywisch
    Stephan Mathas
    Julia Meissner
    Martin Sökler
    Max S. Topp
    Vladan Vucinic
    Andreas Zimmermann
    Bastian von Tresckow
    Michael Fuchs
    Andreas Engert
    Peter Borchmann
    Dennis A. Eichenauer
    Leukemia, 2022, 36 : 580 - 582
  • [43] Two Cycles of ABVD Followed by Involved Field Radiotherapy with 20 Gray (Gy) is the New Standard of Care in the Treatment of Patients with Early Stage Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group (GHSG) Trial HD10
    Mueller, R. P.
    Eich, H. T.
    Pluetschow, A.
    Debus, J.
    Bamberg, M.
    Wilbom, K.
    Eble, M.
    Mueller-Hennelink, H.
    Diehl, V.
    Engert, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S26 - S27
  • [44] Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial
    Gallamini, Andrea
    Tarella, Corrado
    Viviani, Simonetta
    Rossi, Andrea
    Patti, Caterina
    Mule, Antonino
    Picardi, Marco
    Romano, Alessandra
    Cantonetti, Maria
    La Nasa, Giorgio
    Trentin, Livio
    Bolis, Silvia
    Rapezzi, Davide
    Battistini, Roberta
    Gottardi, Daniela
    Gavarotti, Paolo
    Corradini, Paolo
    Cimminiello, Michele
    Schiavotto, Corrado
    Parvis, Guido
    Zanotti, Roberta
    Gini, Guido
    Ferreri, Andres J. M.
    Viero, Piera
    Miglino, Maurizio
    Billio, Atto
    Avigdor, Abraham
    Biggi, Alberto
    Fallanca, Federico
    Ficola, Umberto
    Gregianin, Michele
    Chiaravalloti, Agostino
    Prosperini, Giuseppe
    Bergesio, Fabrizio
    Chauvie, Stephane
    Pavoni, Chiara
    Gianni, Alessandro Massimo
    Rambaldi, Alessandro
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05) : 454 - +
  • [45] No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase II trial from the German Hodgkin Study Group
    Behringer, K.
    Wildt, L.
    Mueller, H.
    Mattle, V.
    Ganitis, P.
    van den Hoonaard, B.
    Ott, H. W.
    Hofer, S.
    Pluetschow, A.
    Diehl, V.
    Engert, A.
    Borchmann, P.
    ANNALS OF ONCOLOGY, 2010, 21 (10) : 2052 - 2060
  • [46] Combined modality treatment of two or four cycles of ABVD followed by involved field radiotherapy in the treatment of patients with early stage Hodgkin's lymphoma: Update interim analysis of the randomised HD10 study of the German Hodgkin study group (GHSG).
    Engert, A
    Pluetschow, A
    Eich, HT
    Herrmann, R
    Doerken, B
    Kanz, L
    Greil, R
    Markova, J
    Pfistner, B
    Josting, A
    Mueller-Hermelink, K
    Mueller, RP
    Diehl, V
    BLOOD, 2005, 106 (11) : 750A - 750A
  • [47] Two Cycles of ABVD Followed by Involved Field Radiotherapy with 20 Gray (Gy) Is the New Standard of Care in the Treatment of Patients with Early-Stage Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group (GHSG) HD10.
    Engert, Andreas
    Diehl, Volker
    Pluetschow, Annette
    Eich, Hans T.
    Herrmann, Richard
    Doerken, Bernd
    Kanz, Lothar
    Greil, Richard
    Markova, Jana
    Fuchs, Michael
    Borchmann, Peter
    Mueller-Hermelink, Hans Konrad
    Mueller, Rolf Peter
    BLOOD, 2009, 114 (22) : 299 - 299
  • [48] Two cycles of ABVD followed by involved field radiotherapy with 20 Gray (Gy) is the new standard of care in the treatment of patients with early-stage Hodgkin lymphoma: final analysis of the randomized German Hodgkin Study Group (GHSG) HD10 study
    Engert, A.
    Diehl, V
    Pluetschow, A.
    Eich, H.
    Herrmann, R.
    Doerken, B.
    Kanz, L.
    Greil, R.
    Markova, J.
    Fuchs, M.
    Borchmann, P.
    Mueller-Hermeling, H. K.
    Mueller, R. P.
    ONKOLOGIE, 2010, 33 : 124 - 124
  • [49] TWO CYCLES OF ABVD FOLLOWED BY INVOLVED FIELD RADIOTHERAPY WITH 20 GRAY (GY) IS THE NEW STANDARD OF CARE IN THE TREATMENT OF PATIENTS WITH EARLY-STAGE HODGKIN LYMPHOMA: FINAL ANALYSIS OF THE RANDOMIZED GERMAN HODGKIN STUDY GROUP (GHSG) HD10 STUDY
    Engert, A.
    Pluetschow, A.
    Eich, H.
    Herrmann, R.
    Doerken, B.
    Kanz, L.
    Greil, R.
    Markova, J.
    Fuchs, M.
    Borchmann, P.
    Mueller-Hermelink, H.
    Mueller, R.
    Diehl, V.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 473 - 473
  • [50] A contribution to solve the problem of the need for consolidative radiotherapy after intensive chemotherapy in advanced stage Hodgkin's lymphoma - Fourth interim analysis of the multicenter randomized trial HD12 of the German Hodgkin study group (GHSG)
    Eich, H. T.
    Mueller, R. P.
    Brillant, C.
    Engert, A.
    Franklin, J.
    Hansemann, K.
    Skripnitchenko, R.
    Staar, S.
    Pfistner, B.
    Diehl, V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S96 - S97
12345